Acute Heart Failure After Myocardial Infarction

We compared two groups of patients after acute myocardial infarction. First group was treated with fibrinolytics and they were hospitalized within six hours from the beginning of the first chest-symptoms, and second group that did not come within optimal time was treated with anticoagulants only. T...

Full description

Bibliographic Details
Main Authors: Amra Macić-Džanković, Belma Pojskić
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2007-02-01
Series:Biomolecules & Biomedicine
Subjects:
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/3088
_version_ 1797260789964341248
author Amra Macić-Džanković
Belma Pojskić
author_facet Amra Macić-Džanković
Belma Pojskić
author_sort Amra Macić-Džanković
collection DOAJ
description We compared two groups of patients after acute myocardial infarction. First group was treated with fibrinolytics and they were hospitalized within six hours from the beginning of the first chest-symptoms, and second group that did not come within optimal time was treated with anticoagulants only. The patients were classified according to Killip-classification, shock-index and TIMI-risk-score after myocardial infarction. Results prove great benefit of fibrinolytic therapy in optimal time, concerning both keeping myocardial muscle mass and myocardial pump function.
first_indexed 2024-04-24T23:30:55Z
format Article
id doaj.art-f13e3bfa1d884bd78bc3475833fce597
institution Directory Open Access Journal
issn 2831-0896
2831-090X
language English
last_indexed 2024-04-24T23:30:55Z
publishDate 2007-02-01
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
record_format Article
series Biomolecules & Biomedicine
spelling doaj.art-f13e3bfa1d884bd78bc3475833fce5972024-03-15T14:42:38ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2007-02-017110.17305/bjbms.2007.3088658Acute Heart Failure After Myocardial InfarctionAmra Macić-Džanković0Belma Pojskić1Department of Cardiology, General Hospital Dr. A. NakasDepartment of Cardiology, Cantonal Hospital Zenica We compared two groups of patients after acute myocardial infarction. First group was treated with fibrinolytics and they were hospitalized within six hours from the beginning of the first chest-symptoms, and second group that did not come within optimal time was treated with anticoagulants only. The patients were classified according to Killip-classification, shock-index and TIMI-risk-score after myocardial infarction. Results prove great benefit of fibrinolytic therapy in optimal time, concerning both keeping myocardial muscle mass and myocardial pump function. https://www.bjbms.org/ojs/index.php/bjbms/article/view/3088heart failureKillip-classificationfibrinolytic therapyanticoagulant therapy
spellingShingle Amra Macić-Džanković
Belma Pojskić
Acute Heart Failure After Myocardial Infarction
Biomolecules & Biomedicine
heart failure
Killip-classification
fibrinolytic therapy
anticoagulant therapy
title Acute Heart Failure After Myocardial Infarction
title_full Acute Heart Failure After Myocardial Infarction
title_fullStr Acute Heart Failure After Myocardial Infarction
title_full_unstemmed Acute Heart Failure After Myocardial Infarction
title_short Acute Heart Failure After Myocardial Infarction
title_sort acute heart failure after myocardial infarction
topic heart failure
Killip-classification
fibrinolytic therapy
anticoagulant therapy
url https://www.bjbms.org/ojs/index.php/bjbms/article/view/3088
work_keys_str_mv AT amramacicdzankovic acuteheartfailureaftermyocardialinfarction
AT belmapojskic acuteheartfailureaftermyocardialinfarction